FDA Panel Backs Second RSV Vaccine for Older Americans

THURSDAY, March 2, 2023 (HealthDay News) -- Following hours of discussion over safety concerns, a U.S. Food and Drug Administration advisory panel on Wednesday recommended approval of a second RSV

Related Keywords

United States ,New York ,Americans ,Hana El Sahly ,Henry Bernstein ,Glaxosmithkline ,Us Centers For Disease ,Drug Administration ,Zucker School Of Medicine At Hofstra University ,Pfizer ,New York Times ,Astrazeneca ,Pfizer Inc ,Healthday News ,New England Journal ,Zucker School ,Hofstra University ,Disease Control ,Consumer News ,